Award
National Cancer Institute 1R50CA293827-01A1
Elucidating and overcoming T cell dysfunction in pancreatic cancer
Recipient
University of Minnesota
Award Amount
$119,858.00
Ceiling
$119,858.00
Awarded
August 05, 2025
Identifier
1R50CA293827-01A1
This award funds research to understand and overcome T cell dysfunction in pancreatic cancer, aiming to improve immunotherapy outcomes. The project is supported by the National Cancer Institute and runs from 2025 to 2030.
Description
The project focuses on immunotherapy resistance in pancreatic ductal adenocarcinoma. It involves developing animal models and testing combinatorial immunotherapy strategies. The award is funded by the National Cancer Institute. The project duration is from August 7, 2025, to July 31, 2030.